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Ultraviolet spectrophotometric (UV) and Liquid Chromatographic (LC) methods for the determination 
of mianserin hydrochloride in pharmaceutical formulation were developed and validated. The various 
parameters, such as specificity, linearity, precision and accuracy were studied according to International 
Conference on Harmonization (ICH, 2005). For UV method, mianserin hydrochloride was determinate 
at 278 nm using HCl 0.1 M as the solvent. The response was linear in the concentration range of 20.0 - 
140.0 µg/mL (r = 0.9998). Precision data evaluated by relative standard deviation was lower than 2%. 
The UV method was simple, rapid and low cost. Chromatographic analyses were performed in an Ace 
C18 column and the mobile phase was composed of methanol, 50 mM monobasic potassium phosphate 
buffer and 0.3% triethylamine solution adjusted to pH 7.0 with phosphoric acid 10% (85:15). LC method 
was specific, linear, precise, exact and robust. The results confirmed that the both methods are valid and 
useful to the routine quality control of mianserin hydrochloride in coated tablets. Statistical analysis by 
Student´s t-test showed no significant difference between the results obtained by UV and LC methods.
Uniterms: Ultraviolet spectrophotometry/qualitative analysis. Liquid chromatographic/qualitative 
analysis. Mianserin hydrochloride/determination in tablets. Coated tablets/qualitative analysis.
Os métodos por espectrofotometria na região do ultravioleta (UV) e por cromatografia líquida (CL) para 
determinação do cloridrato de mianserina na forma farmacêutica foram desenvolvidos e validados. Os 
vários parâmetros, como especificidade, linearidade, precisão e exatidão foram avaliados de acordo 
com o International Conference on Harmonization (ICH, 2005). Para o método de UV, o cloridrato de 
mianserina foi determinado utilizando o comprimento de onda de 278 nm e HCl 0,1 M como solvente. A 
resposta foi linear na faixa de concentração de 20,0 a 140,0 µg/Ml (r = 0,9998). A precisão foi avaliada 
pelo valor de desvio padrão relativo (DPR) inferior a 2%. O método por UV é simples, rápido e de 
baixo custo. As análises cromatográficas foram realizadas em uma coluna Ace C18 e a fase móvel foi 
composta por metanol, tampão fosfato de potássio monobásico 50 mM com 0,3% de trietilamina com o 
pH ajustado para 7,0 com ácido fosfórico 10% (85:15). O método de CL foi específico, linear, preciso, 
exato e robusto. Os resultados confirmam que ambos os métodos são válidos e úteis para o controle de 
qualidade do cloridrato de mianserina em comprimidos revestidos. A análise estatística por teste t de 
Student não mostrou diferença significativa entre os resultados obtidos para os métodos de UV e CL.
Unitermos: Espectrofotometria na região do ultravioleta/análise quantitativa. Cromatografia líquida/
análise quantitativa. Cloridrato de mianserina/determinação em comprimidos. Comprimidos revestidos/
análise qualitativa.
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INTRODUCTION
Mianserin hydrochloride (Figure 1), chemically 
(RS)-2-methyl-1,2,3,4,10,14b -hexahydrodibenzo[c,f]
pyrazino[1,2-α]azepine hydrochloride, is a drug for the 
treatment of depressive illness and depression associated 
with anxiety. The antidepressant mianserin hydrochloride 
exhibits a tetracyclic structure that is different from typical 
tricyclic antidepressants. Based on its mechanism of 
action not defined, mianserin is classified as an atypical 
antidepressant (Pawlowska et al., 2003).
It is metabolized mainly by N-demethylation, aromatic 
hydroxylation, N-oxidation and N-glucuronidation. The 
major metabolite of mianserin hydrochloride in plasma, 
N-desmethylmianserin, contributes substantially to 
the overall therapeutic effects of mianserin in patients 
(Chauhan et al., 2005). 
Although there are s tudies describing the 
determination of mianserin hydrochloride in biological 
fluids by LC-MS (Chauhan et al., 2005), LC-ESI/MS 
(Xu et al., 2008), LC (Hefnawy, Aboul-Enein, 2004; 
Brown, Hundt, Swart, 1992; Lukaszkiewicz et al., 2007) 
and spectrophotometric methods with detection in the 
visible region (Khan et al., 2002; Devani, Pandya, Shah, 
1990), there are no studies describing quantification 
methods by UV spectrophotometry for coated tablets. 
The literature reports few methods for the quantitation 
of  mianser in  hydrochlor ide in  pharmaceut ical 
dosage form. 
The method described in this study was validated 
through the evaluation of the following analytical 
parameters: specificity, linearity, precision (repeatability 
and intermediate precision) and accuracy (ICH, 2005). The 
aim of this study was to develop and validate a simple, fast 
and low cost method by UV spectrophotometry to quantify 
mianserin hydrochloride in coated tablets. Besides, the 
statistical comparison of the results with LC method, 
previously validated by our research group, was performed 
(Sfair et al., 2012).
EXPERIMENTAL PROCEDURES
Material
Mianserin hydrochloride reference standard 
(99.90%) was kindly supplied by Pharmaceutical Industry 
Organon (São Paulo, Brazil) and the commercial tablets 
Tolvon® was obtained in the local pharmaceutical market. 
The tablets were claimed to contain 30 mg of drug and the 
following excipients: starch, silicon dioxide, magnesium 
stearate, methylcellulose, calcium dibasic phosphate, 
hypromellose, macrogol and titanium dioxide. Purified 
water was obtained by a Millipore® Direct-Q 3UV 
with pump (Molsheim, France). Hydrochloric acid was 
purchased from Merck (Darmstadt, Germany).
Instruments and analytical conditions
Spectral and absorbance measurements were 
performed with an UV-Vis Shimadzu model UV 160A 
using 10 mm quartz cells and detection at 278 nm.
The LC system (Agilent 1200 series, Santa Clara, 
USA) consisted of a quaternary pump, vacuum degasser, 
thermostat column compartment, standard auto sampler 
and diode array detector set at 278 nm was used. 
Chromatographic analyses were performed in an Ace 
RP-18 octadecyl silane column (250 mm×4.6 mm i.d., 
particle size 5 µm) maintained at ambient temperature 
(25 ºC). The mobile phase was composed of methanol, 
monobasic potassium phosphate buffer (50 mM) and 0.3% 
triethylamine solution adjusted to pH 7.0 with phosphoric 
acid 10% (85:15, v/v) in isocratic mode at a flow rate of 
1.0 mL/min and the sample injection volume was 20 µL.
Analytical method development
Different solvents were investigated to develop a 
suitable UV-spectrophotometric method for the analysis 
of mianserin hydrochloride in coated tablets. For selection 
of media the criteria employed were sensitivity of the 
method, ease of sample preparation, solubility of the drug 
and cost of solvents. Other parameters were evaluated: 
wavelength and sample concentration, but the focus was 
on the solvent used since one of the goals was to use this 
UV method in the dissolution test.
Method validation
Specificity
A solution was prepared with common excipients 
present in the dosage form (starch, silicon dioxide, 
FIGURE 1 - Chemical structure of mianserin hydrochloride.
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magnesium stearate, methylcellulose, calcium dibasic 
phosphate, hypromellose, macrogol and titanium dioxide), 
the volumetric flask was kept in an ultrasonic bath for 20 
minutes and after the solution was filtered. The solution 
was scanned from 200 to 400 nm. 
Linearity
The calibration curve was obtained with seven 
concentrations of the standard solution (20.0, 40.0, 60.0, 
80.0, 100.0, 120.0 and 140.0 µg/mL) in triplicate. The 
linearity was evaluated by linear regression analysis.
Precision
The precision of the assay was determined by 
repeatability (intra-day) and intermediate precision 
(inter-day). Repeatability was evaluated by assaying 
samples, at same concentration and during the same day. 
The intermediate precision was studied by comparing the 
assays on different days (3 days). Six sample solutions 
(80.0 µg/mL) were prepared and assayed each day. For 
preparation of sample solutions, were used crushed tablets 
and the volumetric flask was kept in an ultrasonic bath for 
20 minutes and after the solution was filtered.
Accuracy
The accuracy was determined by the recovery of 
known amounts of mianserin hydrochloride reference 
standard added to the samples in the beginning of the 
preparative process. The added levels were 25, 50 and 
75% of the 80.0 µg/mL drug concentration.
LC method
The LC method was validated according to ICH. 
The method was specific and linear over the concentration 
range of 50.0–110.0 µg/mL. Adequate results were 
obtained for repeatability, intermediate precision, accuracy 
and robustness.
RESULTS AND DISCUSSION
The development of spectrophotometric methods 
for drugs determinations has increased considerable, 
due to their importance, low cost and simplicity. In this 
study, an UV method was developed and validated for 
mianserin hydrochloride in coated tablets for routine 
use. The experimental conditions were chosen after 
testing different parameters that influence the analysis. 
The choice of the best solvent for samples was prime 
accomplished. Considering the solubility of mianserin 
in methanol, dichloromethane, water and hydrochloric 
acid, which were tested as diluents, hydrochloric acid 
was used, since it is less toxic, can be used in dissolution 
test later and the drug is stable in it. The development 
and validation of a UV spectrophotometric method for 
quantitative determination of mianserin hydrochloride in 
coated tablets at the wavelength of 278 nm using HCl 0.1 
M as the solvent was performed.
The formulation excipients did not interfere, 
demonstrating the specificity of the method (Figure 2). 
To assess the linearity, three standard curves for mianserin 
hydrochloride were constructed by plotting absorbance 
versus concentrations (µg/mL) and showed good linearity 
on the 20.0-140.0 µg/mL range. The representative linear 
equation for this drug was y = 0.0066x + 0.0091 and 
the correlation coefficient was r = 0.9998. The variance 
analysis (P = 0.05) was performed to verify the good fitting 
of the method and the results showed that no deviation 
from linearity was revealed for mianserin (Fcalculated < 
Fcritical). According to ANOVA there is linear regression 
and there is no deviation from linearity.
The low values for relative standard deviation (RSD) 
0.75%; 0.77%; 1.04% (intra-day precision) and 1.08% 
(inter-day precision) showed the good precision of the 
method (Table I).
The accuracy expresses the agreement between the 
accepted value and the value found. The mean recovery 
was found to be 99.65% (Table II).
Comparison between LC and UV methods
The proposed analytical methods were compared 
using statistical analysis. The Student’s t-test was applied 
and did not reveal significant difference between the 
experimental values obtained in the sample analysis by the 
two methods, demonstrating equivalence. The calculated 
t -value (tcalc = 1.13) was found to be less than the critical 
t-value (tcrit = 2.03) at 0.05 significance level (Table III). 
The main difference between techniques is the 
selectivity. LC method is more selective for being a 
separation technique while in UV method more than one 
molecule is able to absorb in the same wavelength. When 
these techniques are applied to coated tablets, UV method 
has limitations since it may suffer interference of the 
formulation excipients. In addition, UV method cannot 
be used in stability studies since degradation products 
can absorb in the same wavelength of the drug, making it 
impossible to quantify both and compromises the accuracy 
of the analytical method.
CONCLUSION
The proposed method was simple, rapid, accurate, 
precise and inexpensive and can be used for routine 
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TABLE III - Results of the determination of mianserin hydrochloride in coated tablets
LC method 
Experimental amount 
(mg/tablet)
R.S.D. (%)
UV method 
Experimental amount 
(mg/tablet)
R.S.D. (%)
Day 1* 29.77 0.39 30.09 0.75
Day 2* 29.98 0.44 30.40 0.77
Day 3* 30.31 0.23 29.89 1.04
* Mean of six determinations.
TABLE II - Accuracy of UV method for determination of 
mianserin hydrochloride
Added 
concentration 
(μg/mL)
Mean concentration 
found 
(μg/mL)
Mean recovery (%) 
± RSD*
20.0 19.94 99.70 ± 1.06
40.0 39.73 99.32 ± 0.72
60.0 59.96 99.93 ± 0.54
* Relative standard deviation (n=3)
TABLE I - Precision of UV method for determination of 
mianserin hydrochloride
Intra-day precision (%) RSD (%)*
Day 1 100.31 0.75
Day 2 101.34 0.77
Day 3 99.64 1.04
Inter-day precision (%) RSD (%)
100.43 1.08
* n=6
FIGURE 2 - UV spectrum of formulation excipients (– .), mianserin hydrochloride reference standard (---) and sample (continuous 
line) in HCl 0.1 M – 80.0 μg/mL.
analysis of mianserin hydrochloride in coated tablets. 
Moreover, the method can be employed to quantify the 
drug in dissolution test in performance quality control of 
the formulation.
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